Viewing Study NCT02711969


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2026-01-02 @ 10:08 AM
Study NCT ID: NCT02711969
Status: COMPLETED
Last Update Posted: 2022-07-22
First Post: 2016-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment
Sponsor: Bukwang Pharmaceutical
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module